Preliminary exploration has revealed that DNAJC3 may promote the malignant progression of gliomas by activating the MAPK–ERK and PI3K–AKT signaling pathways, as well as regulating immune cell infiltration. This evidence concerns the gene DNAJC3 and central nervous system cancer.